lobbying_activities: 1296683

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1296683	2d700ed6-38b0-4ec6-bf77-76bdef84a7d0	Q3	CAPITOL HILL CONSULTING GROUP	72053	PURDUE PHARMA LLP	2012	third_quarter	PHA	Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316)	HOUSE OF REPRESENTATIVES,SENATE	15750		0	0	2012-10-10T16:37:33.080000-04:00